These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 29872128)

  • 1. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
    Schoemans HM; Lee SJ; Ferrara JL; Wolff D; Levine JE; Schultz KR; Shaw BE; Flowers ME; Ruutu T; Greinix H; Holler E; Basak G; Duarte RF; Pavletic SZ;
    Bone Marrow Transplant; 2018 Nov; 53(11):1401-1415. PubMed ID: 29872128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.
    Harris AC; Young R; Devine S; Hogan WJ; Ayuk F; Bunworasate U; Chanswangphuwana C; Efebera YA; Holler E; Litzow M; Ordemann R; Qayed M; Renteria AS; Reshef R; Wölfl M; Chen YB; Goldstein S; Jagasia M; Locatelli F; Mielke S; Porter D; Schechter T; Shekhovtsova Z; Ferrara JL; Levine JE
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):4-10. PubMed ID: 26386318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.
    Duarte RF; Greinix H; Rabin B; Mitchell SA; Basak G; Wolff D; Madrigal JA; Pavletic SZ; Lee SJ
    Bone Marrow Transplant; 2014 Jan; 49(1):49-54. PubMed ID: 23955633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
    Filipovich AH; Weisdorf D; Pavletic S; Socie G; Wingard JR; Lee SJ; Martin P; Chien J; Przepiorka D; Couriel D; Cowen EW; Dinndorf P; Farrell A; Hartzman R; Henslee-Downey J; Jacobsohn D; McDonald G; Mittleman B; Rizzo JD; Robinson M; Schubert M; Schultz K; Shulman H; Turner M; Vogelsang G; Flowers ME
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):945-56. PubMed ID: 16338616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
    Cuvelier GDE; Schoettler M; Buxbaum NP; Pinal-Fernandez I; Schmalzing M; Distler JHW; Penack O; Santomasso BD; Zeiser R; Angstwurm K; MacDonald KPA; Kimberly WT; Taylor N; Bilic E; Banas B; Buettner-Herold M; Sinha N; Greinix HT; Pidala J; Schultz KR; Williams KM; Inamoto Y; Cutler C; Griffith LM; Lee SJ; Sarantopoulos S; Pavletic SZ; Wolff D
    Transplant Cell Ther; 2022 Aug; 28(8):426-445. PubMed ID: 35662591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.
    Paczesny S; Hakim FT; Pidala J; Cooke KR; Lathrop J; Griffith LM; Hansen J; Jagasia M; Miklos D; Pavletic S; Parkman R; Russek-Cohen E; Flowers ME; Lee S; Martin P; Vogelsang G; Walton M; Schultz KR
    Biol Blood Marrow Transplant; 2015 May; 21(5):780-92. PubMed ID: 25644957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of eGVHD App for bedside GVHD assessment in a high-volume BMT center.
    Chhabra P; Kasudhan KS; Khaire N; Kaundal S; Chopra M; Singh C; Jandial A; Jain A; Prakash G; Khadwal A; Malhotra P; Lad DP
    Blood Cell Ther; 2023 Feb; 6(1):18-22. PubMed ID: 37324565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
    Vigorito AC; Campregher PV; Storer BE; Carpenter PA; Moravec CK; Kiem HP; Fero ML; Warren EH; Lee SJ; Appelbaum FR; Martin PJ; Flowers ME;
    Blood; 2009 Jul; 114(3):702-8. PubMed ID: 19470693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2018 update on chronic graft-versus-host disease].
    Inamoto Y
    Rinsho Ketsueki; 2018; 59(10):2300-2306. PubMed ID: 30305539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Inamoto Y; Valdés-Sanz N; Ogawa Y; Alves M; Berchicci L; Galvin J; Greinix H; Hale GA; Horn B; Kelly D; Liu H; Rowley S; Schoemans H; Shah A; Lupo Stanghellini MT; Agrawal V; Ahmed I; Ali A; Bhatt N; Byrne M; Chhabra S; DeFilipp Z; Fahnehjelm K; Farhadfar N; Horn E; Lee C; Nathan S; Penack O; Prasad P; Rotz S; Rovó A; Yared J; Pavletic S; Basak GW; Battiwalla M; Duarte R; Savani BN; Flowers MED; Shaw BE; Petriček I
    Bone Marrow Transplant; 2019 May; 54(5):662-673. PubMed ID: 30531954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.
    Pavletic SZ; Lee SJ; Socie G; Vogelsang G
    Bone Marrow Transplant; 2006 Nov; 38(10):645-51. PubMed ID: 16980994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.
    Shulman HM; Kleiner D; Lee SJ; Morton T; Pavletic SZ; Farmer E; Moresi JM; Greenson J; Janin A; Martin PJ; McDonald G; Flowers ME; Turner M; Atkinson J; Lefkowitch J; Washington MK; Prieto VG; Kim SK; Argenyi Z; Diwan AH; Rashid A; Hiatt K; Couriel D; Schultz K; Hymes S; Vogelsang GB
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):31-47. PubMed ID: 16399567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic gvhd dictionary-eurograft cost action initiative consensus report.
    Zelić Kerep A; Olivieri A; Schoemans H; Lawitschka A; Halter J; Pulanic D; Dickinson A; Greinix HT; Pavletic SZ; Schultz KR; Lee SJ; Wolff D
    Bone Marrow Transplant; 2023 Jan; 58(1):68-71. PubMed ID: 36229646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.
    Bidgoli A; DePriest BP; Saatloo MV; Jiang H; Fu D; Paczesny S
    Transplant Cell Ther; 2022 Oct; 28(10):657-666. PubMed ID: 35830932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease.
    Aisa Y; Mori T; Kato J; Yamane A; Kohashi S; Kikuchi T; Okamoto S
    Int J Hematol; 2013 Feb; 97(2):263-71. PubMed ID: 23371545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
    Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
    Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.
    Kitko CL; Pidala J; Schoemans HM; Lawitschka A; Flowers ME; Cowen EW; Tkaczyk E; Farhadfar N; Jain S; Steven P; Luo ZK; Ogawa Y; Stern M; Yanik GA; Cuvelier GDE; Cheng GS; Holtan SG; Schultz KR; Martin PJ; Lee SJ; Pavletic SZ; Wolff D; Paczesny S; Blazar BR; Sarantopoulos S; Socie G; Greinix H; Cutler C
    Transplant Cell Ther; 2021 Jul; 27(7):545-557. PubMed ID: 33839317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.
    Chronic GVHD Consortium
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1727-1732. PubMed ID: 29476954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.
    Pidala J; Kitko C; Lee SJ; Carpenter P; Cuvelier GDE; Holtan S; Flowers ME; Cutler C; Jagasia M; Gooley T; Palmer J; Randolph T; Levine JE; Ayuk F; Dignan F; Schoemans H; Tkaczyk E; Farhadfar N; Lawitschka A; Schultz KR; Martin PJ; Sarantopoulos S; Inamoto Y; Socie G; Wolff D; Blazar B; Greinix H; Paczesny S; Pavletic S; Hill G
    Transplant Cell Ther; 2021 Aug; 27(8):632-641. PubMed ID: 33836313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.